ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 62

Novel Approach to Quantifying Joint Pathology Via Musculoskeletal Ultrasound in Newly Diagnosed Juvenile Idiopathic Arthritis

Leandra Woolnough1, David Wilkes2, Yassine Kanaan2, Tracey Wright3 and Heather Benham4, 1UT Southwestern Medical Center, DALLAS, TX, 2Texas Scottish Rite Hospital for Children, Dallas, TX, 3Pediatrics/Rheumatology, UT Southwestern Medical Center, Dallas, TX, 4Pediatric Rheumatology, Texas Scottish Rite Hospital for Children, Dallas, TX

Meeting: 2017 Pediatric Rheumatology Symposium

Keywords: Juvenile idiopathic arthritis (JIA) and ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Thursday, May 18, 2017

Title: Clinical and Therapeutic Poster Session

Session Type: Abstract Submissions

Session Time: 5:30PM-7:00PM

Background/Purpose:  The pathology of inflammation in Juvenile Idiopathic Arthritis (JIA), including thickening and vascularization of the synovial membrane, joint effusion and bony erosions, can be detected by musculoskeletal ultrasound (MskUS). Previous studies measured joint effusion and synovial hypertrophy separately. However, it is often hard to distinguish between these two findings within an area of pathology as they are often overlapping and can have similar echogenicity. The objective of this study is to use a novel quantitative approach to characterize MskUS abnormalities in newly diagnosed JIA subjects.

Methods:  Subjects underwent MskUS assessment of bilateral wrists (midcarpal and radiocarpal recesses) and bilateral knees (suprapatellar, medial and lateral recesses) by grey-scale and power Doppler. MskUS scans were performed by an experienced technician. Pathologic lesions were measured across the greatest dimension (mm) independently by two pediatric radiologists blinded to the clinical musculoskeletal exam. Subjects also underwent clinical evaluations including a joint assessment, and calculation of the clinical JIA disease activity score (cJADAS).

Results:  Six subjects (5 oligoarticular and 1 polyarticular JIA) with newly diagnosed DMARD and corticosteroid-naïve JIA by ILAR criteria were evaluated in this cross-sectional study. The median age was 6.3 years (range 2.5, 7.1) and the median disease duration was 5.3 months, (range 2.5, 8.2). There was an equal proportion of male and female subjects. Total number of active joint counts ranged from 1 to 8. Of the 24 bilateral wrists and knees under study, 4 (17%) had clinical synovitis. 58% of the same joints under study had evidence of measurable MskUS pathology. Measurements of lesions ranged from 0.5 to 10mm. The interclass correlation between two independent raters for measurements of pathologic lesions in the suprapatellar recesses was 0.95. The Pearson correlation between cJDAS and total measurements of pathologic lesions was not significant.

Conclusion:  Ultrasonography is a useful tool for joint assessment in JIA. Subclinical ultrasonographic abnormalities are common in this cohort of newly diagnosed JIA subjects. Quantitative measurement of total joint pathology is reliable and reproducible. It may be a useful tool to characterize ultrasonographic abnormalities in JIA when it is difficult to distinguish between synovial hypertrophy and joint effusion. Future longitudinal studies are necessary to determine if quantitative measures of ultrasonographic lesions are reliable in monitoring JIA disease activity across time.


Disclosure: L. Woolnough, None; D. Wilkes, None; Y. Kanaan, None; T. Wright, None; H. Benham, None.

To cite this abstract in AMA style:

Woolnough L, Wilkes D, Kanaan Y, Wright T, Benham H. Novel Approach to Quantifying Joint Pathology Via Musculoskeletal Ultrasound in Newly Diagnosed Juvenile Idiopathic Arthritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 4). https://acrabstracts.org/abstract/novel-approach-to-quantifying-joint-pathology-via-musculoskeletal-ultrasound-in-newly-diagnosed-juvenile-idiopathic-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/novel-approach-to-quantifying-joint-pathology-via-musculoskeletal-ultrasound-in-newly-diagnosed-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology